{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T11:28:40Z","timestamp":1778671720016,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2008,2,28]],"date-time":"2008-02-28T00:00:00Z","timestamp":1204156800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1007\/s10620-008-0199-9","type":"journal-article","created":{"date-parts":[[2008,2,29]],"date-time":"2008-02-29T16:16:29Z","timestamp":1204301789000},"page":"2657-2666","source":"Crossref","is-referenced-by-count":29,"title":["Prophylactic Effect of Irsogladine Maleate Against Indomethacin-Induced Small Intestinal Lesions in Rats"],"prefix":"10.1007","volume":"53","author":[{"given":"Kohei","family":"Kamei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikazu","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naho","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Hatazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kikuko","family":"Amagase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,2,28]]},"reference":[{"key":"199_CR1","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/0016-5085(81)90196-7","volume":"80","author":"BJR Whittle","year":"1981","unstructured":"Whittle BJR (1981) Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology 80:94\u201398","journal-title":"Gastroenterology"},{"key":"199_CR2","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1007\/BF01300266","volume":"31","author":"K Takeuchi","year":"1986","unstructured":"Takeuchi K, Ueki S, Okabe S (1986) Importance of gastric motility in the pathogenesis of indomethacin-induced gastric lesions in rats. Dig Dis Sci 31:1114\u20131122","journal-title":"Dig Dis Sci"},{"key":"199_CR3","first-page":"25","volume":"50","author":"A Konaka","year":"1999","unstructured":"Konaka A, Nishijima M, Tanaka A, Kato S, Takeuchi K (1999) Nitric oxide, superoxide radicals and mast cells in pathogenesis of indomethacin-induced small intestinal lesions in rats. J Physiol Pharmacol 50:25\u201338","journal-title":"J Physiol Pharmacol"},{"key":"199_CR4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000064419","volume":"66","author":"K Takeuchi","year":"2002","unstructured":"Takeuchi K, Miyazawa T, Tanaka A, Kato S, Kunikata T (2002) Pathogenic importance of intestinal hypermotility in NSAID-induced small intestinal damage in rats. Digestion 66:30\u201341","journal-title":"Digestion"},{"key":"199_CR5","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1007\/s10620-006-8045-4","volume":"51","author":"K Takeuchi","year":"2006","unstructured":"Takeuchi K, Yokota A, Tanaka A, Takahira Y (2006) Factors involved in upregulation of inducible nitric oxide synthase in rat small intestine following administration of nonsteroidal anti-inflammatory drugs. Dig Dis Sci 51:1250\u20131259","journal-title":"Dig Dis Sci"},{"key":"199_CR6","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/BF00920471","volume":"17","author":"T Yamada","year":"1993","unstructured":"Yamada T, Deitch E, Specian RD, Perry MA, Sartor RB, Grisham MB (1993) Mechanism of acute and chronic intestinal inflammation induced by indomethacin. Inflammation 17:641\u2013662","journal-title":"Inflammation"},{"key":"199_CR7","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1111\/j.1476-5381.1995.tb15066.x","volume":"116","author":"BJR Whittle","year":"1995","unstructured":"Whittle BJR, Laszlo F, Evans SM, Moncada S (1995) Induction of nitric oxide synthase and microvascular injury in the rat jejunum provoked by indomethacin. Br J Pharmacol 116:2286\u20132290","journal-title":"Br J Pharmacol"},{"key":"199_CR8","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/gast.2000.16510","volume":"119","author":"JL Wallace","year":"2000","unstructured":"Wallace JL, McKnight W, Reuter BK, Vergnolle N (2000) NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2. Gastroenterology 119:706\u2013714","journal-title":"Gastroenterology"},{"key":"199_CR9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0928-4257(01)00005-5","volume":"95","author":"A Tanaka","year":"2001","unstructured":"Tanaka A, Araki H, Hase S, Takeuchi K (2001) Inhibition of both COX-1 and COX-2 is required for development of gastric damage in response to nonsteroidal anti-inflammatory drugs. J Physiol Pari 95:21\u201327","journal-title":"J Physiol Pari"},{"key":"199_CR10","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1124\/jpet.300.3.754","volume":"300","author":"A Tanaka","year":"2002","unstructured":"Tanaka A, Hase S, Miyazawa T, Takeuchi K (2002) Up-regulation of COX-2 by inhibition of COX-1: a key to NSAID-induced intestinal damage. J Pharmacol Exp Ther 300:754\u2013761","journal-title":"J Pharmacol Exp Ther"},{"key":"199_CR11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000007734","volume":"61","author":"S Kato","year":"2000","unstructured":"Kato S, Tanaka A, Kunikata T, Umeda M, Takeuchi K (2000) Protective effect of lafutidine against indomethacin-induced intestinal ulceration in rats: relation to capsaicin-sensitive sensory neurons. Digestion 61:39\u201346","journal-title":"Digestion"},{"key":"199_CR12","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1542-3565(04)00619-6","volume":"3","author":"JL Goldstein","year":"2005","unstructured":"Goldstein JL, Eisen GM, Lewis B, Gralnek IM, Zlotnick S, Fort JG (2005) Investigators. Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo. Clin Gastroenterol Hepatol 3:133\u2013141","journal-title":"Clin Gastroenterol Hepatol"},{"key":"199_CR13","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000094098","volume":"73","author":"Y Mashita","year":"2006","unstructured":"Mashita Y, Taniguchi M, Yokota A, Tanaka A, Takeuchi K (2006) Oral but not parenteral aspirin upregulates COX-2 expression in rat stomachs: a relationship between COX-2 expression and PG deficiency. Digestion 73:124\u2013132","journal-title":"Digestion"},{"key":"199_CR14","first-page":"478","volume":"34","author":"F Ueda","year":"1984","unstructured":"Ueda F, Aratani S, Mimura K, Kimura K, Nomura A, Enomoto H (1984) Effect of 2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine maleate (MN-1695) on gastric mucosal damage induced by various necrotizing agents in rats. Arzneim Forsch 34:478\u2013484","journal-title":"Arzneim Forsch"},{"key":"199_CR15","first-page":"815","volume":"274","author":"F Ueda","year":"1995","unstructured":"Ueda F, Ban K, Ishima T (1995) Irsogladine activates gap-junctional intercellular communication through M1 muscarinic acetylcholine receptor. J Pharmacol Exp Ther 274:815\u2013819","journal-title":"J Pharmacol Exp Ther"},{"key":"199_CR16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.lfs.2004.06.016","volume":"76","author":"T Kyoi","year":"2004","unstructured":"Kyoi T, Noda K, Oka M, Ukai Y (2004) Irsogladine, an anti-ulcer drug, suppresses superoxide production by inhibiting phosphodiesterase type 4 in human neutrophils. Life Sci 76:71\u201383","journal-title":"Life Sciences"},{"key":"199_CR17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0014-2999(87)90649-2","volume":"142","author":"K Yamasaki","year":"1987","unstructured":"Yamasaki K, Kanbe T, Chijiwa T, Ishiyama H, Morita S (1987) Gastric mucosl protection by OPC-12759, a novel antiulcer compound in the rat. Eur J Pharmacol 142:23\u201329","journal-title":"Eur J Pharmacol"},{"key":"199_CR18","first-page":"799","volume":"31","author":"M Murakami","year":"1981","unstructured":"Murakami M, Oketani K, Fujisaki H, Wakabayashi T, Ohgo T (1981) Antiulcer effect of geranylgeranylacetone, a new acyclic polyisoprenoid on experimentally induced gastric and duodenal ulcers in rats. Arzneimittelforschung 31:799\u2013804","journal-title":"Arzneimittelforschung"},{"key":"199_CR19","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1172\/JCI114164","volume":"84","author":"EA Deitch","year":"1989","unstructured":"Deitch EA, Ma L, Ma WJ, Grisham MB, Granger DN, Specian RD, Berg RD (1989) Inhibition of endotoxin-induced bacterial translocation in mice. J Clin Invest 84:36\u201342","journal-title":"J Clin Invest"},{"key":"199_CR20","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0014-4894(74)90070-8","volume":"36","author":"GA Castro","year":"1974","unstructured":"Castro GA, Roy SA, Srockstill RD (1974) Trichinella spioralis: peroxydase activity in isolated cells from the rat intestine. Exp Parasitol 36:307\u2013315","journal-title":"Exp Parasitol"},{"key":"199_CR21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0014-2999(92)90567-N","volume":"229","author":"A Calignano","year":"1992","unstructured":"Calignano A, Whittle BJR, Di Rosa M, Moncada S (1992) Involvement of endogenous nitric oxide in the regulation of rat intestinal motility in\u00a0vivo. Eur J Pharmacol 229:273\u2013276","journal-title":"Eur J Pharmacol"},{"key":"199_CR22","first-page":"33","volume":"14","author":"A Robert","year":"1987","unstructured":"Robert A, Asano T (1987) Resistance of germ-free rats to indomethacin-induced intestinal inflammation. Prostaglandins 14:333\u2013341","journal-title":"Prostaglandins"},{"key":"199_CR23","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1007\/s10620-006-8045-4","volume":"51","author":"K Takeuchi","year":"2006","unstructured":"Takeuchi K, Yokota A, Tanaka A (2006) Factors involved in upregulation of inducible nitric oxide synthase in rat small intestine following administration of nonsteroidal anti-inflammatory drugs. Dig Dis Sci 51:1250\u20131259","journal-title":"Dig Dis Sci"},{"key":"199_CR24","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1111\/j.1476-5381.1993.tb13940.x","volume":"110","author":"N Boughton-Smith","year":"1993","unstructured":"Boughton-Smith N, Evans SM, Laszlo F, Whittle BJR, Moncada S (1993) The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat. Br J Pharmacol 110:1189\u20131195","journal-title":"Br J Pharmacol"},{"key":"199_CR25","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1046\/j.1440-1746.2001.02592.x","volume":"16","author":"H Mizoguchi","year":"2001","unstructured":"Mizoguchi H, Miyazawa T, Ogawa Y, Tanaka A, Takeuchi K (2001) Protective effect of rebamipide on indomethacin-induced intestinal damage in rats. J Gastroenterol Hepatol 16:1112\u20131119","journal-title":"J Gastroenterol Hepatol"},{"key":"199_CR26","first-page":"51","volume":"33","author":"A Yokota","year":"2005","unstructured":"Yokota A, Ohno R, Takahira Y, Tanaka A, Takeuchi K (2005) Protective effect of teprenone against indomethacin-induced small intestinal lesions in rats. Jpn Pharmacol Ther 33:51\u201361","journal-title":"Jpn Pharmacol Ther"},{"key":"199_CR27","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1023\/A:1014725024519","volume":"47","author":"T Kunikata","year":"2002","unstructured":"Kunikata T, Tanaka A, Miyazawa T, Kato S, Takeuchi K (2002) 16,16-Dimetyl prostaglandin E2 inhibits indomethacin-induced small intestinal lesions through EP3 and EP4 receptors. Dig Dis Sci 47:894\u2013904","journal-title":"Dig Dis Sci"},{"key":"199_CR28","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/S0006-2952(99)00286-5","volume":"58","author":"S Takahashi","year":"1999","unstructured":"Takahashi S, Takeuchi K, Okabe S (1999) EP4 receptor mediation of prostaglandin E2-stimulated mucus secretion by rabbit gastric epithelial cells. Biochem Pharmacol 58:1997\u20132002","journal-title":"Biochem Pharmacol"},{"key":"199_CR29","first-page":"205","volume":"46","author":"RA Coleman","year":"1994","unstructured":"Coleman RA, Smith WL, Narumiya S (1994) Classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 46:205\u2013229","journal-title":"Pharmacol Rev"},{"key":"199_CR30","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000199296","volume":"33","author":"A Terano","year":"1986","unstructured":"Terano A, Hiraishi H, Ota S, Sugimoto T (1986) Geranylgeranylacetone, a novel anti-ulcer drug, stimulates mucus synthesis and secretion in rat gastric cultured cells. Digestion 33:206\u2013210","journal-title":"Digestion"},{"key":"199_CR31","first-page":"1462","volume":"42","author":"K Ishihara","year":"1992","unstructured":"Ishihara K, Komuro Y, Nishiyama N, Yamasaki K, Hotta K (1992) Effect of rebamipide on mucus secretion by endogenous prostaglandin-independent mechanism in rat gastric mucosa. Arzneimittelforschung 42:1462\u20131466","journal-title":"Arzneimittelforschung"},{"key":"199_CR32","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1124\/jpet.102.041715","volume":"303","author":"A Tanaka","year":"2002","unstructured":"Tanaka A, Hase S, Ohno R, Takeuchi K (2002) Roles of COX-1 and COX-2 inhibition in NSAID-induced intestinal damage in rats. J Pharmacol Exp Ther 303:1248\u20131254","journal-title":"J Pharmacol Exp Ther"},{"key":"199_CR33","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/sj.bjp.0701968","volume":"124","author":"V Bertrand","year":"1998","unstructured":"Bertrand V, Guimbaud R, Tulliez M, Mauprivez C, Sogni P, Couturier D, Giroud JP, Chaussade S, Chauvelot-Moachon L (1998) Increase in tumor necrosis factor-a production linked to the toxicity of indomethacin for the rat small intestine. Br J Pharmacol 124:1385\u20131394","journal-title":"Br J Pharmacol"},{"key":"199_CR34","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0022-3565(24)37847-4","volume":"287","author":"DE Griswoold","year":"1998","unstructured":"Griswoold DE, Webb EF, Badger AM, Gorycki PD, Levandoski PA, Bannette MA, Grous M, Christensen S, Torphy TJ (1998) SB 207499 (Ariflo), a second generation phsphodiestrase 4 inhibitor, reduces tumor necrosis factor a and interleukin-4 production in\u00a0vivo. J Pharmacol Exp Ther 287:705\u2013711","journal-title":"J Pharmacol Exp Ther"},{"key":"199_CR35","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.expneurol.2007.08.011","volume":"208","author":"CM Atkins","year":"2007","unstructured":"Atkins CM, Oliva AA, Alonso OF, Pearse DD, Bramlett HM, Dietrich WD (2007) Modulation of the cAMP signaling pathway after traumatic brain injury. Exp Neurol 208:145\u2013158","journal-title":"Exp Neurol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-008-0199-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-008-0199-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-008-0199-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T21:09:36Z","timestamp":1738098576000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-008-0199-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,28]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["199"],"URL":"https:\/\/doi.org\/10.1007\/s10620-008-0199-9","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,28]]}}}